Peninsula biotech looks to turn once-failed osteoporosis drug against rare disease

A Bay Area company went on the hunt for a certain class of drugs that could level off calcium levels in both the blood and urine. Now it plans to take a drug into a late-stage clinical trial for people at risk of deadly kidney disease.